ATAI Life Sciences AG Revenue and Competitors
Estimated Revenue & Valuation
- ATAI Life Sciences AG's estimated annual revenue is currently $21.2M per year.
- ATAI Life Sciences AG's estimated revenue per employee is $155,000
- ATAI Life Sciences AG's total funding is $347.1M.
- ATAI Life Sciences AG's current valuation is $2B.
Employee Data
- ATAI Life Sciences AG has 137 Employees.
- ATAI Life Sciences AG grew their employee count by 12% last year.
ATAI Life Sciences AG's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, CEO & MD | Reveal Email/Phone |
2 | Chief Accounting Officer (CAO) | Reveal Email/Phone |
3 | General Counsel & Corporate Development Lead | Reveal Email/Phone |
4 | VP, atai Impact | Reveal Email/Phone |
5 | VP, Head Biostatistics | Reveal Email/Phone |
6 | VP CMC | Reveal Email/Phone |
7 | VP, Digital Therapeutics | Reveal Email/Phone |
8 | VP, Commercial Strategy | Reveal Email/Phone |
9 | SVP, Clinical Development | Reveal Email/Phone |
10 | VP, Nonclinical Development | Reveal Email/Phone |
ATAI Life Sciences AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $16.9M | 109 | 11% | N/A | N/A |
#2 | $51.1M | 297 | 4% | $109M | $747M |
What Is ATAI Life Sciences AG?
Who we are: ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. Our mission: We are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. Our approach: By pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.
keywords:N/A
$347.1M
Total Funding
137
Number of Employees
$21.2M
Revenue (est)
12%
Employee Growth %
$2B
Valuation
N/A
Accelerator
ATAI Life Sciences AG News
Gregory Weaver, CFO of atai Life Sciences, with over 25 years in the life ... the Group NOXXON Pharma N.V. and NOXXON Pharma AG has not...
Many #biotech stocks are cheap at the moment. In my opinion, Atai Life Sciences AG stands out though for two reasons: the size of the market (...
Among noteworthy developments in the space, Novartis AG NVS announced the FDA nod ... Atai Life Sciences N.V. ATAI (before the market open)
ATAI Life Sciences, the Peter Thiel-backed umbrella developer of psychedelics and other drugs for mental health conditions, launched a new portfolio company Thursday. The new outfit is called Revixia Life Sciences, and its mission is to bring the main active ingredien ...
Peter Thiel (Neilson Barnard/Getty Images) Investor interest in psychedelic-based medicine has increased over the last several years amid growing support from regulators, clinicians and patients. In the latest move in the space, Atai Life Sciences, a Peter Thiel-backed startup that is developin ...
Other Companies in Berlin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20M | 138 | 2% | N/A |
#2 | $29M | 138 | 16% | N/A |
#3 | $34.6M | 138 | -12% | N/A |
#4 | $27.9M | 138 | -5% | N/A |
#5 | $45.2M | 139 | N/A | N/A |